SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

Share Price is delayed by 15 minutes
Get Live Data
17.50    0.00 (0.00%)
Bid:
17.00
Ask:
18.00
Spread: 1.00 (5.882%)
Market Cap: £15.85m
TMG Live PriceLast checked at - London Stock Exchange

Intraday The Mission Group Share Chart

Trading Update

19 Jan 2022 07:00

RNS Number : 8685Y
Mission Group PLC (The)
19 January 2022
Β 

19 January 2022

THEΒ MISSION GROUP plc

Β 

("MISSION", "the Group")Β 

Β 

TRADING UPDATE AND NOTICE OF RESULTS

TheΒ MISSIONΒ Group plcΒ (AIM: TMG), creator ofΒ Work ThatΒ CountsΒ comprising a network of 16 Agencies delivering real, sustainable growth for its Clients, today issues a trading update for the year ended 31 December 2021.

Trading update

Β 

MISSIONΒ continuedΒ to deliver an impressive andΒ strongΒ sequential trading recovery throughout the second half of the financial year.Β As a direct consequence,Β the Group was pleased to achieve anΒ outstanding increase in profit levels against both H1 2021 and FY2020Β and so expectsΒ a healthyΒ full year headline PBT performanceΒ that isΒ in line with market expectations.

Β 

Whilst trading conditions throughout 2021 remained challenging, due to the impact and disruption caused by the evolving pandemic on the Group's markets, the resilience of MISSION'S business model has underpinned its continued ability to deliver against this backdrop.

Further strategic progress has been made over the course of the year to expand MISSION'S Agency portfolio with the acquisition of Soul, a full-service customer engagement Agency that works with psychologists to help businesses better understand human nature and human behaviour, enhancingΒ MISSION's creative and customer experience capability.

The Group has also benefitted from a full year of the now fully embedded behavioural science practice, Innovation Bubble, acquired in 2020. MISSION expects to continue to grow its roster of Agencies in 2022, alongside investing in building additional and enhanced capability to further support its Clients.

The development of its people also continues to be of key strategic importance to the Group and in 2022 MISSION will invest at record levels in recruiting and retaining the best talent. Whilst the Group recognises this will have some short-term impact on its cost base, it will ultimately underpin its ability to deliver in future years.

Strong cash management remains a key priority for the Group and, even after settling its last significant earn-out obligation, its year end net bank debt was Β£10.2m, in line with market expectations and giving MISSION significant headroom against its current debt facility. The highly cash generative nature of the Group means it is well placed to capitalise on the opportunities that 2022 will undoubtedly bring.

Whilst uncertainties remain about Covid-19 and its impact on the economy over theΒ currentΒ year, the BoardΒ isΒ confident that the Group is well positioned for sustainable growth andΒ expects toΒ achieve double-digitΒ year on year PBT growth in 2022.

Β 

Notice of results

Β 

The Group expects to announce its final results on 29 March 2022.

James Clifton, Chief Executive ofΒ TheΒ MISSION Group plc, commented:Β "I am pleased thatΒ MISSION's strong trading momentum has continued, demonstrating our continued ability to deliver growth againstΒ an ever changing andΒ challenging backdrop.

"Over the course of the year we have further strengthened the Group and our market proposition, meaning we are increasingly well positioned to continue to progress against our strategic priorities in 2022 and beyond. The coming year will see us place a significant focus on our biggest and most important asset - our people - as we look to recruit and retain the best talent to provide the best service to our Clients."

Β 

ENQUIRIES:

James Clifton, Chief Executive Officer

GilesΒ Lee, Chief Financial Officer

TheΒ MISSIONΒ Group plc

Β 

Β 

020 7462 1415

Β 

Β 

Mark PercyΒ /Β James ThomasΒ /Β Fiona Conroy

Shore Capital (Nomad and Broker)

020 7408 4090

Β 

Β 

Β 

Kate HoareΒ /Β Laura Stewart

HOUSTONΒ (Financial PR and Investor Relations)

0204 529 0549

Β 

NOTES TO EDITORS

Β 

MISSIONΒ is a collective of Creative and MarTech Agencies led by entrepreneurs who encourage an independent spirit.Β Employing 1,000 people across 27 locations and 3 continents, the Group successfully combines its diverse expertise to produceΒ Work ThatΒ CountsΒ for our Clients, whatever their ambitions. Creating real standout, sharing real innovation and delivering real business growth for some of the world's biggest brands.Β www.themission.co.uk

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTUWRBRUNUAAAR
Date   Source Headline
19th Sep 20137:00 amRNSInterim results for the six months to 30 June 2013
30th Aug 20137:00 amRNSNotice of Interim Results
19th Jul 20137:00 amRNSDirector Exercise of Options & EBT dealing
17th Jul 20137:00 amRNSDirector Dealing
16th Jul 20137:00 amRNSDirectors' Exercise of Options
12th Jul 20137:00 amRNSDirector/PDMR Shareholding
11th Jul 20134:11 pmRNSAnnual LTIP Awards and Vesting; EBT Share Dealings
11th Jul 20137:00 amRNSDirector/PDMR Shareholding
10th Jul 20137:00 amRNSTrading Update
17th Jun 201312:30 pmRNSResult of AGM
12th Apr 20134:45 pmRNSDirector/PDMR Shareholding
11th Apr 20134:55 pmRNSDirector Dealing
10th Apr 20137:00 amRNSDirector Shareholding
3rd Apr 20137:00 amRNSDirector/PDMR Shareholding
28th Mar 20137:02 amRNSDirectors' Dealing
27th Mar 20134:10 pmRNSRegistered Office & Availability of Annual Report
25th Mar 20137:00 amRNSFinal Results
22nd Mar 20138:36 amRNSReplacement Notice of Results
22nd Mar 20137:00 amRNSNotice of Results
6th Mar 20137:00 amRNSDirectorate Change
1st Mar 20137:00 amRNSDirectorate Change
28th Jan 20137:00 amRNSTrading Update
25th Jan 20137:00 amRNSNew Client win and further expansion
9th Nov 20127:00 amRNSDirector/PDMR Shareholding
5th Nov 20127:00 amRNSDirector/PDMR Shareholding
19th Oct 201211:44 amRNSHolding(s) in Company
16th Oct 20122:59 pmRNSHolding(s) in Company
12th Oct 20127:00 amRNSAcquisition, Placing and Board Appointment
24th Sep 20127:00 amRNSAcquisition of Addiction Worldwide
19th Sep 20128:19 amRNSHalf Yearly Report
14th Sep 20123:14 pmRNSNotice of Half Year Results
20th Jul 20127:00 amRNSIssue of LTIP Awards
18th Jul 20127:01 amRNSPre Close Trading Update
18th Jul 20127:00 amRNSChange of Adviser
18th Jun 20121:03 pmRNSResult of AGM
18th Jun 201212:00 pmRNSDirectorate Change
31st May 20121:30 pmRNSContract Award
14th May 20124:04 pmRNSDirector/PDMR Shareholding
8th May 20122:01 pmRNSDirector/PDMR Shareholding
4th May 20122:47 pmRNSDirector/PDMR Shareholding
1st May 20127:00 amRNSDirector/PDMR Shareholding
16th Apr 20123:34 pmRNSHolding(s) in Company
27th Mar 20127:00 amRNSFinal Results
22nd Mar 20127:00 amRNSNotice of Results
26th Jan 20127:00 amRNSTrading Statement
24th Jan 20127:00 amRNSDirector/PDMR Shareholding
6th Jan 20129:13 amRNSDirector/PDMR Shareholding
21st Nov 20114:17 pmRNSDirector/PDMR Shareholding
3rd Oct 20112:44 pmRNSDirector/PDMR Shareholding
30th Sep 20117:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.